Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03596060Unknown
Randomised, open-label trial of propofol injection (veterinary) and levobupivacaine in hip fracture, sponsored by University Hospital of Larissa. Primary endpoint: All-cause mortality at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03596060.